Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort

Detalhes bibliográficos
Autor(a) principal: Assunção, Helena
Data de Publicação: 2022
Outros Autores: Jesus, Diogo, Larosa, Maddalena, Henriques, Carla, Matos, Ana, Le Guern, Véronique, Rubiño, Francisco, Silva, José A P da, Rua-Figueroa, Iñigo, Costedoat-Chalumeau, Nathalie, Doria, Andrea, Inês, Luís S
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.19/7406
Resumo: Objectives To derive and validate a definition of low disease activity (LDA) for SLE based on the SLE Disease Activity Score (SLE-DAS), in a real-life multicentre cohort of SLE patients. Methods Derivation was conducted using data from a monocentric cohort of SLE (Portugal), and validation was performed in a multicentre cohort (Italy, France and Spain). The Lupus Low Disease Activity State (LLDAS) was used as comparator. We applied receiver operating characteristics curve analysis against the LLDAS to determine the cut-off of SLE-DAS for LDA using bootstrap methodology. In a second step, we tested a definition of SLE-DAS LDA that included: (i) the statistically derived SLE-DAS upper threshold for LDA and (ii) prednisone dose ≤7.5 mg/day. In the multicentre validation cohort, we assessed the classification performance of this SLE-DAS LDA definition. Results We included 774 patients, 300 in the derivation and 474 in the validation cohort. In the derivation cohort, the optimal cut-off to identify patients in LLDAS was SLE-DAS ≤2.48, presenting an area under the curve of 0.965 (95% CI 0.935, 0.994). When applied to the multicentre validation cohort, the SLE-DAS LDA definition showed a sensitivity of 97.1% and a specificity of 97.7% for LLDAS and an almost perfect agreement (Cohen’s Kappa = 0.933; P < 0.001). McNemar’s test found no significant differences between the two definitions (P = 0.092). Conclusion The SLE-DAS LDA is a validated, accurate and easy-to-use definition for classifying SLE patients in LDA state.
id RCAP_8732a132941e6016b1211e91c6f56be2
oai_identifier_str oai:repositorio.ipv.pt:10400.19/7406
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohortsystemic lupus erythematosustreat-to-targetSLE-DASLLDASObjectives To derive and validate a definition of low disease activity (LDA) for SLE based on the SLE Disease Activity Score (SLE-DAS), in a real-life multicentre cohort of SLE patients. Methods Derivation was conducted using data from a monocentric cohort of SLE (Portugal), and validation was performed in a multicentre cohort (Italy, France and Spain). The Lupus Low Disease Activity State (LLDAS) was used as comparator. We applied receiver operating characteristics curve analysis against the LLDAS to determine the cut-off of SLE-DAS for LDA using bootstrap methodology. In a second step, we tested a definition of SLE-DAS LDA that included: (i) the statistically derived SLE-DAS upper threshold for LDA and (ii) prednisone dose ≤7.5 mg/day. In the multicentre validation cohort, we assessed the classification performance of this SLE-DAS LDA definition. Results We included 774 patients, 300 in the derivation and 474 in the validation cohort. In the derivation cohort, the optimal cut-off to identify patients in LLDAS was SLE-DAS ≤2.48, presenting an area under the curve of 0.965 (95% CI 0.935, 0.994). When applied to the multicentre validation cohort, the SLE-DAS LDA definition showed a sensitivity of 97.1% and a specificity of 97.7% for LLDAS and an almost perfect agreement (Cohen’s Kappa = 0.933; P < 0.001). McNemar’s test found no significant differences between the two definitions (P = 0.092). Conclusion The SLE-DAS LDA is a validated, accurate and easy-to-use definition for classifying SLE patients in LDA state.Repositório Científico do Instituto Politécnico de ViseuAssunção, HelenaJesus, DiogoLarosa, MaddalenaHenriques, CarlaMatos, AnaLe Guern, VéroniqueRubiño, FranciscoSilva, José A P daRua-Figueroa, IñigoCostedoat-Chalumeau, NathalieDoria, AndreaInês, Luís S2022-11-18T11:08:46Z2022-08-032022-11-16T18:31:14Z2022-08-03T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.19/7406eng1462-0324cv-prod-263000010.1093/rheumatology/keab895metadata only accessinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-01-16T15:29:34Zoai:repositorio.ipv.pt:10400.19/7406Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:45:08.618097Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
title Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
spellingShingle Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
Assunção, Helena
systemic lupus erythematosus
treat-to-target
SLE-DAS
LLDAS
title_short Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
title_full Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
title_fullStr Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
title_full_unstemmed Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
title_sort Definition of Low Disease Activity State based on the SLE-DAS: Derivation and validation in a multicentre real-life cohort
author Assunção, Helena
author_facet Assunção, Helena
Jesus, Diogo
Larosa, Maddalena
Henriques, Carla
Matos, Ana
Le Guern, Véronique
Rubiño, Francisco
Silva, José A P da
Rua-Figueroa, Iñigo
Costedoat-Chalumeau, Nathalie
Doria, Andrea
Inês, Luís S
author_role author
author2 Jesus, Diogo
Larosa, Maddalena
Henriques, Carla
Matos, Ana
Le Guern, Véronique
Rubiño, Francisco
Silva, José A P da
Rua-Figueroa, Iñigo
Costedoat-Chalumeau, Nathalie
Doria, Andrea
Inês, Luís S
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico de Viseu
dc.contributor.author.fl_str_mv Assunção, Helena
Jesus, Diogo
Larosa, Maddalena
Henriques, Carla
Matos, Ana
Le Guern, Véronique
Rubiño, Francisco
Silva, José A P da
Rua-Figueroa, Iñigo
Costedoat-Chalumeau, Nathalie
Doria, Andrea
Inês, Luís S
dc.subject.por.fl_str_mv systemic lupus erythematosus
treat-to-target
SLE-DAS
LLDAS
topic systemic lupus erythematosus
treat-to-target
SLE-DAS
LLDAS
description Objectives To derive and validate a definition of low disease activity (LDA) for SLE based on the SLE Disease Activity Score (SLE-DAS), in a real-life multicentre cohort of SLE patients. Methods Derivation was conducted using data from a monocentric cohort of SLE (Portugal), and validation was performed in a multicentre cohort (Italy, France and Spain). The Lupus Low Disease Activity State (LLDAS) was used as comparator. We applied receiver operating characteristics curve analysis against the LLDAS to determine the cut-off of SLE-DAS for LDA using bootstrap methodology. In a second step, we tested a definition of SLE-DAS LDA that included: (i) the statistically derived SLE-DAS upper threshold for LDA and (ii) prednisone dose ≤7.5 mg/day. In the multicentre validation cohort, we assessed the classification performance of this SLE-DAS LDA definition. Results We included 774 patients, 300 in the derivation and 474 in the validation cohort. In the derivation cohort, the optimal cut-off to identify patients in LLDAS was SLE-DAS ≤2.48, presenting an area under the curve of 0.965 (95% CI 0.935, 0.994). When applied to the multicentre validation cohort, the SLE-DAS LDA definition showed a sensitivity of 97.1% and a specificity of 97.7% for LLDAS and an almost perfect agreement (Cohen’s Kappa = 0.933; P < 0.001). McNemar’s test found no significant differences between the two definitions (P = 0.092). Conclusion The SLE-DAS LDA is a validated, accurate and easy-to-use definition for classifying SLE patients in LDA state.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-18T11:08:46Z
2022-08-03
2022-11-16T18:31:14Z
2022-08-03T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.19/7406
url http://hdl.handle.net/10400.19/7406
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 1462-0324
cv-prod-2630000
10.1093/rheumatology/keab895
dc.rights.driver.fl_str_mv metadata only access
info:eu-repo/semantics/openAccess
rights_invalid_str_mv metadata only access
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130922778361856